Cambridge Investment Research Advisors’s Invesco BulletShares 2031 Corporate Bond ETF BSCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
115,599
+1,929
+2% +$32.1K ﹤0.01% 1620
2025
Q4
$1.9M Buy
113,670
+33,488
+42% +$560K 0.01% 1567
2025
Q3
$1.34M Buy
80,182
+13,307
+20% +$221K ﹤0.01% 1819
2025
Q2
$1.1M Sell
66,875
-3,217
-5% -$52.4K ﹤0.01% 1866
2025
Q1
$1.14M Buy
70,092
+29,702
+74% +$480K ﹤0.01% 1752
2024
Q4
$648K Buy
40,390
+27,004
+202% +$440K ﹤0.01% 2217
2024
Q3
$223K Buy
13,386
+618
+5% +$10.1K ﹤0.01% 3056
2024
Q2
$204K Buy
12,768
+523
+4% +$8.32K ﹤0.01% 3012
2024
Q1
$197K Buy
12,245
+188
+2% +$3.03K ﹤0.01% 3028
2023
Q4
$198K Buy
+12,057
New +$187K ﹤0.01% 2910

Other funds holding BSCV

Cambridge Investment Research Advisors's BSCV Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Invesco BulletShares 2031 Corporate Bond ETF (BSCV) stake by 1.7% in Q1 2026, buying an estimated $32.1K and bringing the position to 115,599 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Cambridge Investment Research Advisors first reported a position in BSCV in Q4 2023 and has held it in 10 quarters since. 213 funds tracked by Wall St. Rank hold BSCV as of Q1 2026.

  • Cambridge Investment Research Advisors held 115,599 shares of Invesco BulletShares 2031 Corporate Bond ETF worth $1.9M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 1,929 Invesco BulletShares 2031 Corporate Bond ETF shares in Q1 2026, an estimated $32.1K.
  • Invesco BulletShares 2031 Corporate Bond ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1620 holding.
  • Cambridge Investment Research Advisors first reported a position in Invesco BulletShares 2031 Corporate Bond ETF in Q4 2023 and has held it in 10 quarters since.
  • 213 funds tracked by Wall St. Rank held Invesco BulletShares 2031 Corporate Bond ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.